Atlas Trials

Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery

Clinical trial NCT03307616 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03307616
Sponsor
M.D. Anderson Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Dedifferentiated LiposarcomaRecurrent Dedifferentiated LiposarcomaRecurrent Undifferentiated Pleomorphic SarcomaResectable Dedifferentiated LiposarcomaResectable Undifferentiated Pleomorphic SarcomaUndifferentiated Pleomorphic Sarcoma
Start date
2017-10-04
Primary completion
2027-10-31
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.